Concepedia

Matthew T. Harbison

MT

Statistics

Publications

8

Citations

1.9K

H-Index

8

Active since

1996

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Centre for Cancer Biology

Matthew T. Harbison is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and pancreatic cancer.

Publications per year

1996–2002

8

Publications

8

Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.

Christiane J. Bruns, Carmen C. Solórzano, Matthew T. Harbison et al. · PubMed · 2000 · 501 citations

Medicine, Oncology, Pharmacology +17

Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.

Christiane J. Bruns, Matthew T. Harbison, Darren W. Davis et al. · PubMed · 2000 · 422 citations

Medicine, Oncology, Pharmacology +17

In Vivo Selection and Characterization of Metastatic Variants from Human Pancreatic Adenocarcinoma by Using Orthotopic Implantation in Nude Mice

Christiane J. Bruns, Matthew T. Harbison, Hiroki Kuniyasu et al. · Neoplasia · 1999 · 350 citations · Full text

Medicine, Cell Biology, Oncology +16

Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts.

Steffan T. Nawrocki, Christiane J. Bruns, Matthew T. Harbison et al. · PubMed · 2002 · 172 citations

Medicine, Oncology, Pharmacology +17

CREB and Its Associated Proteins Act as Survival Factors for Human Melanoma Cells

Didier Jean, Matthew T. Harbison, David J. McConkey et al. · Journal of Biological Chemistry · 1998 · 166 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

1–5 of 8